- Home
- GNS vs STRO Comparison
GNS vs STRO Comparison
Compare GNS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- STRO
- Stock Information
- Founded
- GNS 2002
- STRO 2003
- Country
- GNS Singapore
- STRO United States
- Employees
- GNS N/A
- STRO N/A
- Industry
- GNS Other Consumer Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNS Real Estate
- STRO Health Care
- Exchange
- GNS Nasdaq
- STRO Nasdaq
- Market Cap
- GNS 72.9M
- STRO 69.1M
- IPO Year
- GNS 2022
- STRO 2018
- Fundamental
- Price
- GNS $1.02
- STRO $0.88
- Analyst Decision
- GNS
- STRO Hold
- Analyst Count
- GNS 0
- STRO 8
- Target Price
- GNS N/A
- STRO $3.83
- AVG Volume (30 Days)
- GNS 4.4M
- STRO 504.1K
- Earning Date
- GNS 04-30-2025
- STRO 08-07-2025
- Dividend Yield
- GNS N/A
- STRO N/A
- EPS Growth
- GNS N/A
- STRO N/A
- EPS
- GNS N/A
- STRO N/A
- Revenue
- GNS $7,912,718.00
- STRO $104,473,000.00
- Revenue This Year
- GNS $62.23
- STRO N/A
- Revenue Next Year
- GNS $69.63
- STRO N/A
- P/E Ratio
- GNS N/A
- STRO N/A
- Revenue Growth
- GNS N/A
- STRO N/A
- 52 Week Low
- GNS $0.21
- STRO $0.52
- 52 Week High
- GNS $1.92
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- GNS 49.91
- STRO 59.29
- Support Level
- GNS $0.81
- STRO $0.76
- Resistance Level
- GNS $1.08
- STRO $0.83
- Average True Range (ATR)
- GNS 0.13
- STRO 0.06
- MACD
- GNS -0.01
- STRO -0.00
- Stochastic Oscillator
- GNS 51.10
- STRO 59.03
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.